As community cancer care providers who experience first-hand the challenges of providing quality cancer care, ACCC members are the best positioned to educate decision-makers on how coverage and reimbursement issues affect community oncology.
ACCC provides members with the information and resources needed to effectively advocate on the issues that are important to them. Together, we can positively influence the future of community oncology.
ACCC believes that to improve the current treatment options available for patients at the lowest cost without decreasing access to care, the following four principles should be taken into consideration.
Any proposed changes in reimbursement for drugs, diagnostics, and biomarker testing should decrease health inequities and not negatively impact the ability of cancer programs and practices to provide necessary supportive care services for potentially disadvantaged patients.
On-Demand Webinar: The 2023 Medicare PFS and OPPS Proposed Rules: What You Need to Know
Learn about the key proposals in the CY 2023 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) proposed rules and how these proposed changes to Medicare payment will impact oncology practices, freestanding cancer centers, and hospital-based cancer programs in 2023. There will be an opportunity for live Q&A.
Speakers:
Teri Bedard, BA, RT(R)(T), CPC
Executive Director, Client & Corporate Resources
Revenue Cycle Coding Strategies, Inc
Matt Devino, MPH
Director, Cancer Care Delivery and Health Policy
Association of Community Cancer Centers
On July 7, CMS issued the (CY) 2023 Physician Fee Schedule (PFS) proposed rule, which would significantly expand access to behavioral health services, Accountable Care Organizations (ACOs), cancer screening, and dental care—particularly in rural and underserved areas.
On July 15, CMS issues the (CY) 2023 Hospital Outpatient Prospective Payment System (OPPS) proposed rule. In addition to proposing payment rates, this year’s rule includes proposals that align with several key goals of the Administration, including advancing health equity in rural areas, promoting competition in the health care system, and promoting safe, effective, and patient-centered care. The proposed rule would further the agency’s commitment to strengthening Medicare and use the lessons learned from the COVID-19 PHE to inform the approach to quality measurement.
On November 1, the Centers for Medicare and Medicaid Services (CMS) released the CY 2023 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) Final Rules, finalizing the agency's new reimbursement policies taking effect January 1, 2023. ACCC will host a virtual in-depth review of these final rules and their anticipated impact on oncology programs and practices as part of our 2022 Oncology Reimbursement Meetings. Register for the upcoming webinar on December 13 and view the final rules and their corresponding CMS fact sheets below:
CY 2023 Medicare Payment Resource
This member-exclusive resource provides a high-level summary of Medicare coding and reimbursement policies finalized by the Centers for Medicare and Medicaid Services (CMS) in its calendar year (CY) 2023 rulemaking cycle. Highlights include Medicare policy changes included in the CY 2023 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules, including updates to the Medicare Quality Payment Program (QPP).
If you are looking for legislative action, look no further than your state's legislatures. Most—if not all—states have had issues relating to oncology care and healthcare in general come up during their 2023 sessions.
For 2023, ACCC members have identified four core areas of focus (e.g., reimbursement, utilization management, provider-patient choice), among a larger set of issues and concerns, that the association will be supporting this year.
Today is National Caregivers Day, and ACCCBuzz analyzes the current mental health crisis that is affecting the caregivers of loved ones everywhere.